(Q47355331)

English

Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.

scientific article published on 30 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

6

object named as

Manfred Dietel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

object named as

Holger Moch

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Sven Perner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Niels J Rupp

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Martin Braun

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nicolas Wernert

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Carsten Stephan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Glen Kristiansen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

30 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

807-812

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Antibody-based detection of ERG rearrangement-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies-experience at the Charité Hospital Berlin, Campus Mitte.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Identifiers

10.1002/IJC.27733

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47355331&oldid=1797598149"